SEC Form 4 · accession 0001179110-16-028199
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Thomas
Director
Period of report
Aug 1, 2016
Accepted (ET)
Aug 3, 2016 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par value | Aug 1, 2016 | M | 10,000 | $18.94 | A | 31,311 | D | |
| Common Stock, $.01 par valueF3 | Aug 1, 2016 | S | 10,000 | $118.6547 | D | 21,311 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1,F2 | $18.94 | Aug 1, 2016 | M | 10,000 | D | Jan 29, 2014 | May 26, 2020 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F2These options become exerciseable as following: 50% on the date shown in Table II, Column 6, and 50% on January 29, 2015.
- F3This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $118.5000 and $118.9100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.